Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03997812 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
A Phase 2 study of Pain, Postoperative, sponsored by Vivozon.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT03997812: Completed Phase 2 study of Pain, Postoperative, sponsored by Vivozon.
NCT03997812 is a Phase 2 study of Pain, Postoperative that has completed, run by Vivozon. The registered enrollment target is 60 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03997812, a Phase 2 study of Pain, Postoperative, has completed, sponsored by Vivozon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.
Primary Outcome
Using Numeric Pain Rating Scale (NRS, 0-10 at rest)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG VVZ-149 Injections
Study Locations (2)
California
- Anaheim Clinical Trials - Anaheim
Utah
- JBR Clinical Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-05-23 |
| Est. Completion | 2019-08-21 |
| Phase | Phase 2 |
What the finished NCT03997812 record still lists
NCT03997812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03997812 reports a single indexed study location in California, Utah.
Frequently Asked Questions
What is clinical trial NCT03997812 about?
NCT03997812 is a clinical study titled "Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy". The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.
What is the current status of trial NCT03997812?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2019-05-23. Estimated completion is 2019-08-21.
What conditions does trial NCT03997812 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT03997812?
The interventions under investigation include: Placebo (DRUG), VVZ-149 Injections (DRUG).
Who is sponsoring clinical trial NCT03997812?
This trial is sponsored by Vivozon, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03997812 being conducted?
This trial has 2 study locations across California, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03997812's enrollment target sits among peer trials
60 79th of 113 higher than 30 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
RECRUITING · Phase 2
-
Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population
RECRUITING · Phase 2
-
Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children
RECRUITING · Phase 2
-
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
ACTIVE NOT RECRUITING · Phase 2
-
Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management
COMPLETED · Phase 2
-
Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI